Our academic collaborators’ seminal contributions push the field forward
Our constellation of renowned thinkers and partners
The right collaborators across pharma, biotech and nonprofit
The next generation of scientific leaders in cancer immunotherapy
Stories & Announcements
PICI in the News
Resources for Press
01
Funding the Future of Cancer Research: The Parker Institute for Cancer Immunotherapy Awards Nearly $3 Million to Six Early Career Researchers
02
Improving Conventional Wisdom: From CAR-T Therapy to Diversity in STEM, Avery Posey Has Big Ideas
03
Ute Dugan Joins the Parker Institute for Cancer Immunotherapy as Senior Vice President of Clinical Research
Develop breakthrough immune therapies to turn all cancers into curable diseases faster
The driving force behind PICI’s research and operations
Transformative science requires visionary philanthropy
Join us. Change lives.
All researchers have data from their studies. But data means little studied in isolation. Our BioTrust centralizes and standardizes patient samples, assay data and clinical outcomes from our network’s research projects and clinical trials to fuel next-level science. Our deeply comprehensive collection is shared throughout our network so that we’re not only igniting smarter research, but growing our own knowledge base at the same time – providing the foundation to advance discovery in patient diagnosis and treatment.
60K
Biospecimens
Transitional Suite Assays
Cheryl Selinsky, PhD Vice President, Research Operations
Christopher Perry Associate Director, Biospecimen Acquisition and Operations
Nikesh Kotecha, PhD Vice President, Informatics
Pier Federico Gherardini, PhD Director, Informatics
Nicholas Bayless, PhD Senior Research Scientist
Lacey Kitch, PhD Director, Informatics
Theresa LaVallee, PhD Vice President, Translational Medicine and Regulatory Affairs